The Magazine

Issue 8

- Issue 8
  Jul 2009
- Issue 7
  Apr 2009
- Issue 6
  Nov 2008
- Issue 5
  Apr 2008
- Issue 4
  Nov 2007
- Issue 3
  Mar 2007
- Issue 2
  Mar 2006
- Issue 1
  Feb 2006

View All

Blog

Where our team of editors discuss what they think about the current NGP US Issues.

Marie Shields
Editor NGP Europe

The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.
05 Aug 2009

Focus Areas

Cover Stories

The Small Company That Grew

Once a minor force in the world pharmaceutical market, Nycomed became a major player following its acquisition of Altana Pharma in 2006. CEO...

Winner takes all

The competition between branded drugs and generic copies has been going on for years, but as generics threaten to take the lead, how will...

In with the new

When Chris Viehbacher arrived to take up the reins as CEO of sanofi-aventis at the end of last year, he found a company with an image problem...

More Like This

Roundtables

Challenges in drug development and delivery

John Fraher of Eurand and Gerd Paulus of Swiss BioAnalytics talk to NGP about common problems in developing successful pharmaceutical products.
Read more
Keeping it Lean

NGP talks to four industry experts about the applications of Lean and Six Sigma in pharmaceutical manufacturing. With JMP, R&G Global Consultants, SI Associates, and...
Read more
The importance of CRM

CRM Roundtable with Rob Halkes of Van Spaendonck, Vivian Hunt of McKinsey & Company and CDM’s Torben Vogt.
Read more
Strategies for successful marketing

Four experts give NGP the inside scoop on the latest techniques for establishing and promoting brand awareness. With Corbett Accel Healthcare Group’s Scott Cotherman, Grey...
Read more

More Like This

Vendor Perspectives

Cyclobenzaprine ER: partnering for succe...

By Eurand. Patients’ unmet needs due to inconvenient dosing and significant side effects with existing therapies led to the collaboration to develop Amrix®, the first and...
Read more
Like a bridge over troubled waters: Neow...

Bringing a new drug to market is one of the riskiest ventures in the business world. Ms. Ayelet Dilion-Mashiah, VP Business Development at Do-Coop Technologies, explains...
Read more
High functionality in a very compact space

Compact process layouts with Robolux valves from Bürkert.
Read more
One-click global regulatory overview in ...

Actavis, one of the world’s leading generic pharmaceutical firms, launched CDM Regulatory Manager in 2005. The solution is implemented in 65 countries, enabling a...
Read more
The see vs. solve challenge

By Aegis Analytical. Manufacturers are continuously working to improve processes for better yields, faster time to market and fewer regulatory investigations. Aegis...
Read more
Nature Publishing Group and Biocentury l...

The publisher of Nature, the world’s most prestigious science journal, and Biocentury, a leading provider of intelligence on the pharmaceutical and biotech industry, have...
Read more

More Like This

Industry Analysts

Utilising cutting-edge water-based nanotec...

By Ayelet Dilion-Mashiah, Do-Coop Technologies Ltd. Bringing a new drug to market is one of the most expensive procedures in the business world. As the costs of new drug...
Read more
Sound responses to the changing late-phase...

Safety concerns in drug development, both from the public and regulators, have clearly intensified – and there will be no let up. By Dipti Amin, Quintiles
Read more
Strategic choices to reduce acetonitrile d...

By Richard Lake, Restek Corporation. In today’s economic climate, laboratory productivity is an increasingly important key to bringing new drugs to market efficiently, and...
Read more
Towards more affordable and innovative pha...

Abhijit Mukherjee of Dr. Reddy’s explains the current woes currently facing the pharmaceutical industry.
Read more
An airfreight-focused logistics solution

By Martin Svantesson, Geodis Wilson
Read more
Laboratory asset management strategies

Masao Moriyama explains how using a single provider for the management of laboratory equipment throughout its entire lifecycle reduces administration, improves efficiency...
Read more